Matula, Z.; Bekő, G.; Király, V.; Gönczi, M.; Zóka, A.; Baráth, A.; Uher, F.; Vályi-Nagy, I.
Long-Term SARS-CoV-2-Specific Humoral and T Cell Responses after the BNT162b2 or BBIBP-CorV Booster and the Incidence of Breakthrough Infections among Healthcare Workers. Vaccines 2024, 12, 3.
https://doi.org/10.3390/vaccines12010003
AMA Style
Matula Z, Bekő G, Király V, Gönczi M, Zóka A, Baráth A, Uher F, Vályi-Nagy I.
Long-Term SARS-CoV-2-Specific Humoral and T Cell Responses after the BNT162b2 or BBIBP-CorV Booster and the Incidence of Breakthrough Infections among Healthcare Workers. Vaccines. 2024; 12(1):3.
https://doi.org/10.3390/vaccines12010003
Chicago/Turabian Style
Matula, Zsolt, Gabriella Bekő, Viktória Király, Márton Gönczi, András Zóka, András Baráth, Ferenc Uher, and István Vályi-Nagy.
2024. "Long-Term SARS-CoV-2-Specific Humoral and T Cell Responses after the BNT162b2 or BBIBP-CorV Booster and the Incidence of Breakthrough Infections among Healthcare Workers" Vaccines 12, no. 1: 3.
https://doi.org/10.3390/vaccines12010003
APA Style
Matula, Z., Bekő, G., Király, V., Gönczi, M., Zóka, A., Baráth, A., Uher, F., & Vályi-Nagy, I.
(2024). Long-Term SARS-CoV-2-Specific Humoral and T Cell Responses after the BNT162b2 or BBIBP-CorV Booster and the Incidence of Breakthrough Infections among Healthcare Workers. Vaccines, 12(1), 3.
https://doi.org/10.3390/vaccines12010003